Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients

(2009) Jörg J Vehreschild et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry

(2009) Jörg J. Vehreschild et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The changing face of epidemiology of invasive fungal disease in Europe

(2009) Cornelia Lass-Flörl   MYCOSES

Numbers Needed to Treat with Posaconazole Prophylaxis to Prevent Invasive Fungal Infection and Death

(2008) Oliver A. Cornely et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

(2008) Oliver A. Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Treatment of invasive candidiasis with echinocandins

(2008) Andreas Glöckner et al.   MYCOSES